ANIP - ANI Pharmaceuticals beats by $0.08 beats on revenue February, 27 2019 08:36 AM ANI Pharmaceuticals Inc. ANI Pharmaceuticals (NASDAQ:ANIP): Q4 Non-GAAP EPS of $1.32 beats by $0.08; GAAP EPS of $0.46 beats by $0.02. More news on: ANI Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...